Angina patients with no obstructive CAD had no worse outcomes over 15 years, perhaps because they got the care they needed.
The US Food and Drug Administration has approved the use of lerodalcibep (Lerochol) to reduce LDL cholesterol alongside ...
The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.
The match didn’t cause a “mismatch of supply and demand” but did reveal an opportunity to create change, experts say.
The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.
Understanding the athlete heart in light of normal aging and CV risk requires a nuanced look at imaging findings, the paper ...
The vast majority of what we do would be eliminated if people fix their diet,” says cardiologist Kim Allan Williams Sr.
It’s not yet known whether a fibroid diagnosis could enhance risk stratification or how best to prevent ASCVD in these ...
Thomas Crawford meets with C. Michael Gibson to discuss the role of reconditioned pacemakers in low- and middle-income ...
Survival, quality of life, and efficacy remained similar in the 3 years after TAVI for patients with versus without blockages ...
Among adults older adults, a respiratory syncytial virus (RSV) infection increases the risk of cardiovascular events over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback